• Explore /
  • Poster
  • / CA209-8YD: A phase I/II trial of rucaparib in combination with ramucirumab with or without nivolumab in previously treated advanced gastroesophageal adenocarcinoma (GEA) (RiME).

CA209-8YD: A phase I/II trial of rucaparib in combination with ramucirumab with or without nivolumab in previously treated advanced gastroesophageal adenocarcinoma (GEA) (RiME).

Abstract Poster

Authors

Anwaar Saeed

Anwaar Saeed

Kansas University Cancer Center, Kansas City, KS

Anwaar Saeed , Robin Park , Raed Moh'd Taiseer Al-Rajabi , Anup Kasi , Azhar Saeed , Elizabeth Ng , Kayra Thompson , Stephanie Moya , Lori Barbosa , Milind Phadnis , Stephen K. Williamson , Joaquina Celebre Baranda , Weijing Sun , Daniel V.T. Catenacci

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Gastrointestinal Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session A: Cancers of the Esophagus and Stomach and Other GI Cancers

Track

Esophageal and Gastric Cancer,Other GI Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT03995017

DOI

10.1200/JCO.2022.40.4_suppl.TPS377

Abstract #

TPS377

Poster Bd #

M9

Abstract Disclosures

Similar Posters

First Author: Karim Fizazi

First Author: Vaibhav Sahai

First Author: Daisuke Takahari

First Author: John Ebben